Dilated Cardiomyopathy (DCM) Clinical Trials

9 recruiting

Dilated Cardiomyopathy (DCM) Trials at a Glance

9 actively recruiting trials for dilated cardiomyopathy (dcm) are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Chicago, Wuhan, and Essen. Lead sponsors running dilated cardiomyopathy (dcm) studies include Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Rocket Pharmaceuticals Inc., and Prolaio.

Browse dilated cardiomyopathy (dcm) trials by phase

Treatments under study

About Dilated Cardiomyopathy (DCM) Clinical Trials

Looking for clinical trials for Dilated Cardiomyopathy (DCM)? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dilated Cardiomyopathy (DCM) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dilated Cardiomyopathy (DCM) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Rocket Pharmaceuticals Inc.8 enrolled3 locationsNCT07137338
Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

Heart FailureHypertensionDilated Cardiomyopathy+9 more
Prolaio5,000 enrolled1 locationNCT07420907
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

The Application of T1 Mapping in Real-World

Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Second Affiliated Hospital, School of Medicine, Zhejiang University330 enrolled1 locationNCT07293338
Recruiting

UIC Multi-Ethnic DCM Registry

Heart FailureDilated Cardiomyopathy (DCM)
University of Illinois at Chicago1,500 enrolled1 locationNCT07145138
Recruiting
Not Applicable

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

Dilated Cardiomyopathy (DCM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT06922851
Recruiting

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1,000 enrolled1 locationNCT06741995
Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Hypertrophic Cardiomyopathy (HCM)Non-ischemic CardiomyopathyRestrictive Cardiomyopathy+2 more
Scientific Institute San Raffaele15,000 enrolled1 locationNCT06607471